KR7290650001
KR7290650001
L&C BIO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 85.476.414.990 | 72.032.432.110 | 18.7% |
| Cost of Revenue | 40.087.891.760 | 36.356.595.270 | 10.3% |
| Gross Profit | 45.388.523.230 | 35.675.836.840 | 27.2% |
| 40.972.809.000 | 31.806.666.000 | 28.8% | |
| Operating Income | 4.415.714.230 | 3.869.170.840 | 14.1% |
| Pretax Income | -160.033.866.150 | 139.821.698.080 | 214.5% |
| Net Income Common Stockholders | -138.174.717.180 | 141.595.744.540 | 197.6% |
| -- | -- | -- | |
| -- | -- | -- |